Litcius/Paper detail

Voretigene Neparvovec for Treating Inherited Retinal Dystrophies Caused by RPE65 Gene Mutations: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Appraisal

Caroline Farmer, Ash Bullement, David Packman, Linda Long, Sophie Robinson, Elham Nikram, Anthony J. Hatswell, G. J. Meléndez‐Torres, Louise Crathorne

2020PharmacoEconomics24 citationsDOI

Topics & Concepts

RPE65NiceHealth economicsPerspective (graphical)MedicinePublic healthHealth administrationRetinalBioinformaticsOphthalmologyBiologyPathologyComputer scienceProgramming languageRetinal pigment epitheliumArtificial intelligenceRetinal Development and DisordersRetinopathy of Prematurity StudiesRetinal Diseases and Treatments
Voretigene Neparvovec for Treating Inherited Retinal Dystrophies Caused by RPE65 Gene Mutations: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Appraisal | Litcius